Intended Use

SyMRI is a post-processing software medical device intended for use in visualization of soft tissue, analyzing input data from MR imaging systems to generate parametric maps of R1, R2 relaxation rates, and proton density. It enables automatic labeling, visualization and volumetric quantification of segmentable brain tissues and can generate multiple image contrasts with post-acquisition contrast adjustment. It is indicated for head imaging and aids trained physicians in diagnosis interpretation.

Technology

SyMRI operates by post-processing multi-delay, multi-echo MR acquisitions (M2D-MDME and 3D-QALAS sequences) to produce parametric maps (R1, R2, PD) and synthetic contrast weighted images. It uses segmentation algorithms on parametric maps to quantify brain tissue volumes and supports post-acquisition contrast adjustment. It accepts sequence data from multiple MR vendors and produces outputs compatible with DICOM workstations and PACS.

Performance

Non-clinical verification confirmed accuracy and precision of R1, R2, and PD quantification comparable to gold standards and predicate device. Clinical testing in a prospective, multi-center study with 189 subjects and five radiologist readers demonstrated that synthetic 3D images produced by SyMRI are non-inferior to conventional 3D MR images in sensitivity, specificity, diagnostic accuracy, artifact prevalence, and anatomical legibility, supporting safety and effectiveness.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    8/23/2024

    3 months
  • 2

    FDA Approval

    12/6/2024

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.